Catalyst Wire Dossier Catalyst Wire Dossier

Ondansetron HCl orally disintegrating tablets

ondansetron hydrochloride · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ondansetron HCl orally disintegrating tablets, covering 2009-08-25 to 2009-08-25. Get the full timeline:

Most recent: Clinical Trial Update: Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions [Phase 1]

See pricing